Title : Spontaneous binding of potential COVID-19 drugs (Camostat and Nafamostat) to human serine protease TMPRSS2.

Pub. Date : 2021

PMID : 33505639






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Recent studies showed that two drugs, Camostat and Nafamostat, might be repurposed to treat COVID-19 by inhibiting human TMPRSS2 required for proteolytic activation of viral spike (S) glycoprotein. nafamostat transmembrane serine protease 2 Homo sapiens